APA način citiranja

Levy, D. S., Farkas, H., Riedl, M. A., Hsu, F. I., Brooks, J. P., Cicardi, M., . . . Reshef, A. (2020). Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: Subgroup analysis from an open-label extension of a phase 3 trial. Allergy Asthma Clin Immunol.

Čikaški stil citiranja

Levy, Donald S., Henriette Farkas, Marc A. Riedl, Florence Ida Hsu, Joel P. Brooks, Marco Cicardi, Henrike Feuersenger, Ingo Pragst, i Avner Reshef. "Long-term Efficacy and Safety of Subcutaneous C1-inhibitor in Women With Hereditary Angioedema: Subgroup Analysis From an Open-label Extension of a Phase 3 Trial." Allergy Asthma Clin Immunol 2020.

MLA način citiranja

Levy, Donald S., et al. "Long-term Efficacy and Safety of Subcutaneous C1-inhibitor in Women With Hereditary Angioedema: Subgroup Analysis From an Open-label Extension of a Phase 3 Trial." Allergy Asthma Clin Immunol 2020.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.